Effects of hormone treatment in transsexual women and HIV-positive transvestites or at high risk of HIV infectio

Not Applicable

Recruiting

• Conditions: HIV; AIDS; Transgender Persons; M01.777.500

• Registration Number: RBR-4g23g5
• Lead Sponsor: Insituto Nacional de Infectologia Evandro Chagas/Instituto de Pesquisa Clinica Evandro Chagas

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-26
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

• Persons with a gender assigned at birth and who identify themselves as transgender Women or a gender other than the male
• Age equal or above 18 years
• Documented HIV infection; OR
• History of sexual risk behavior in the past 12 months, including: acquisition of an STD; report of unprotected anal / neovaginal sexual intercourse; difficulty in negotiating condom use;

Exclusion Criteria

Any condition of the volunteer that, in the opinion of the investigator, may make her participation unsafe, complicate the interpretation of the study data or interfere in the study objectives

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate prevalence of non-alcoholic fatty liver disease among transgender women HIV-positive or at risk of HIV infection using FibroScan

Secondary Outcome Measures

Name	Time	Method
To evaluate prevalence of cardiovascular disease among transgender women HIV-positive or at risk of HIV infection, estimated by the carotid intimal thickness, measured by the carotid ultrassonography (Manheim protocol) and brachial artery dilation